Výsledky vyhledávání - "M H, Follansbee"

Studies on pyrazinoylguanidine. 6. Prevention of cataracts in STZ-diabetic rats

Autor: M H, Follansbee, K H, Beyer, E S, Vesell

Publikováno v: Pharmacology. 54(5)

This study was designed to determine whether pyrazinoylguanidine (PZG) can attenuate cataract development in streptozotocin (STZ)-induced diabetic rats. After a single, intraperitoneal dose of STZ (45 mg/kg in 0.05 mol/l sodium citrate buffer), Sprag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ed71c754f4a6327cbdecd31c3919b0c0
https://pubmed.ncbi.nlm.nih.gov/9380771

Zobrazit plný text záznamu

Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats

Autor: M H, Follansbee, K H, Beyer, J W, Griffith, E S, Vesell

Publikováno v: Pharmacology. 54(5)

This study was designed to determine whether pyrazinoylguanidine (PZG) can attenuate diabetic nephropathy in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced within 1 week after a single intraperitoneal dose of STZ (45 mg/kg in 0.05 m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2d6904b29e377531112c7e5538aa23b1
https://pubmed.ncbi.nlm.nih.gov/9380770

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání